Seroprevalence and associated risk factors of Toxoplasma gondii infection in patients undergoing hemodialysis and health
- PDF / 989,922 Bytes
- 5 Pages / 595.276 x 790.866 pts Page_size
- 66 Downloads / 195 Views
BMC Research Notes Open Access
RESEARCH NOTE
Seroprevalence and associated risk factors of Toxoplasma gondii infection in patients undergoing hemodialysis and healthy group Shahrzad Soltani , Mehdi Sagha Kahvaz , Sheyda Soltani , Fatemeh Maghsoudi and Masoud Foroutan*
Abstract Objectives: In this study, the seroprevalence of anti-Toxoplasma gondii (T. gondii) specific antibodies in patients undergoing hemodialysis compared to the control group were evaluated. In this case–control study, 200 hemodialysis patients (HDP) and 100 healthy controls were participated. The specific antibodies (IgG/IgM) in both groups were tested using enzyme-linked immunosorbent assay (ELISA) method. A structured questionnaire containing some demographic information was completed for each person in case and control groups. Results: The overall seroprevalence of T. gondii infection was 49.5% (99/200) and 23.0% (23/100) in the case and control groups, respectively. There was a significant association between seroprevalence of T. gondii infection and contact with cats (P
Data Loading...
